Henrico-based researchers launch COVID-19 treatment study
and last updated 2021-03-02 08:50:18-05 HENRICO, Va. -- Since the fall, Dr. Robert Call, M.D. has led the AstraZeneca COVID-19 vaccine trial at Henrico-based Clinical Research Partners. With 1,800 participants, Call said it's the largest study in the world for the vaccine. Now, researchers are embarking on a new study to help combat the COVID-19 virus. The ACTIVE-2 study will focus on potential COVID-19 therapies that are safe and effective in treating symptoms of the virus. The study, now in phase 2 and 3 of trials, is sponsored by the National Institute of Allergy and Infectious Diseases ...